| Report | Options implied | Actual move | Market was |
|---|---|---|---|
| May 6, 2026 | ±4.4% | -1.2% | over-priced |
| November 6, 2025 | ±4.7% | -2.5% | over-priced |
| August 7, 2025 | ±3.4% | -0.6% | over-priced |
| May 8, 2025 | ±3.3% | +2.1% | over-priced |
| November 5, 2024 | ±1.4% | +1.4% | over-priced |
| August 8, 2024 | ±4.4% | +1.9% | over-priced |
| May 9, 2024 | ±2.5% | +0.2% | over-priced |
| November 8, 2023 | ±2.4% | +2.5% | under-priced |
| Quarter | EPS (dil.) | Revenue | Net income |
|---|---|---|---|
| Q1 FY2026 | $1.71 | $2.8B | $230M |
| Q4 FY2025 | $1.49 | $2.9B | $201M |
| Q3 FY2025 | $1.64 | $2.9B | $223M |
| Q2 FY2025 | $1.34 | $2.7B | $184M |
Expeditors International of Washington, Inc. (EXPD) reports in 98 days, with the next report estimated for September 19, 2026. Across the last 8 reports, options priced an average ±3.3% earnings move while the stock actually moved 1.5% on average — the market has systematically over-priced EXPD's earnings risk. Fundamentals into the print: EPS up 16.3% year-over-year, revenue up 4.4%. QuantLogix's live 5-factor engine currently reads EXPD as a buy at 64/100.
Implied move is derived from at-the-money option pricing; actual moves are close-to-close on report days. Next-report dates are estimates until confirmed by the company. Educational market analysis, not investment advice. Browse all signal scorecards →